Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F9P1L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,234
Award facts
- Contract value 100% obligated
- $37,233.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $37,233.88 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order falls within AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle. The contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices. Repatha (evolocumab), a PCSK9 inhibitor used for cholesterol management, represents the type of specialty pharmaceutical that falls within the scope of this prime vendor agreement, which serves customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F9P1L?
SPE2DR26F9P1L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F9P1L worth?
The government has obligated $37,234 on SPE2DR26F9P1L.
Is contract SPE2DR26F9P1L an order under another contract?
Yes. SPE2DR26F9P1L is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P1L competed?
The extent of competition for SPE2DR26F9P1L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award